Mehadrin (MEDN) Ratios
Mehadrin Ratios
IL:MEDN's free cash flow for Q2 2026 was $186.15M. For the 2026 fiscal year, IL:MEDN's free cash flow was decreased by $-6.18M and operating cash flow was $192.34M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 2.11 | 2.04 | 1.06 | 1.17 | 1.42 |
| Quick Ratio | 1.64 | 1.41 | 0.84 | 0.87 | 1.11 |
| Cash Ratio | 0.46 | 0.24 | 0.20 | 0.21 | 0.37 |
| Solvency Ratio | 0.18 | -0.03 | -0.15 | -0.07 | 0.27 |
| Operating Cash Flow Ratio | 0.08 | -0.00 | 0.01 | -0.05 | -0.02 |
| Short-Term Operating Cash Flow Coverage | 0.74 | -0.34 | 0.01 | -0.10 | -0.03 |
| Net Current Asset Value | $ -73.97M | $ -157.65M | $ -111.71M | $ -78.71M | $ -15.92M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.27 | 0.33 | 0.33 | 0.33 | 0.33 |
| Debt-to-Equity Ratio | 0.75 | 0.83 | 0.75 | 0.70 | 0.64 |
| Debt-to-Capital Ratio | 0.43 | 0.45 | 0.43 | 0.41 | 0.39 |
| Long-Term Debt-to-Capital Ratio | 0.37 | 0.40 | 0.03 | 0.11 | 0.14 |
| Financial Leverage Ratio | 2.74 | 2.49 | 2.27 | 2.15 | 1.96 |
| Debt Service Coverage Ratio | 2.73 | 0.11 | -0.24 | -0.12 | 0.76 |
| Interest Coverage Ratio | 0.67 | -3.00 | -6.12 | -4.38 | 10.56 |
| Debt to Market Cap | 0.41 | 0.52 | 0.72 | 0.87 | 0.59 |
| Interest Debt Per Share | 152.14 | 121.37 | 138.43 | 135.13 | 138.23 |
| Net Debt to EBITDA | 1.54 | -21.62 | -3.04 | -7.88 | 1.16 |
| Profitability Margins | |||||
| Gross Profit Margin | 4.81% | -2.33% | -1.03% | -8.28% | 4.90% |
| EBIT Margin | 14.10% | -6.78% | -13.10% | -7.48% | 18.88% |
| EBITDA Margin | 17.62% | -1.70% | -9.27% | -3.97% | 22.52% |
| Operating Profit Margin | 1.69% | -8.18% | -14.01% | -7.49% | 18.11% |
| Pretax Profit Margin | 11.58% | -9.51% | -15.39% | -9.19% | 17.17% |
| Net Profit Margin | 11.74% | -7.65% | -13.66% | -8.53% | 13.44% |
| Continuous Operations Profit Margin | 11.89% | -7.49% | -13.63% | -8.46% | 13.50% |
| Net Income Per EBT | 101.40% | 80.51% | 88.75% | 92.86% | 78.27% |
| EBT Per EBIT | 686.54% | 116.24% | 109.86% | 122.79% | 94.78% |
| Return on Assets (ROA) | 7.22% | -5.77% | -11.75% | -6.61% | 10.30% |
| Return on Equity (ROE) | 19.76% | -14.40% | -26.71% | -14.19% | 20.18% |
| Return on Capital Employed (ROCE) | 1.35% | -8.03% | -21.71% | -9.69% | 20.87% |
| Return on Invested Capital (ROIC) | 1.31% | -6.21% | -13.07% | -6.56% | 12.77% |
| Return on Tangible Assets | 7.56% | -5.77% | -11.75% | -6.85% | 10.65% |
| Earnings Yield | 12.33% | -11.09% | -31.78% | -21.87% | 23.20% |
| Efficiency Ratios | |||||
| Receivables Turnover | 3.07 | 3.62 | 5.80 | 7.48 | 7.58 |
| Payables Turnover | 5.68 | 7.80 | 10.17 | 11.00 | 12.18 |
| Inventory Turnover | 5.35 | 5.30 | 8.59 | 6.93 | 6.94 |
| Fixed Asset Turnover | 2.65 | 3.37 | 3.54 | 3.00 | 2.89 |
| Asset Turnover | 0.61 | 0.75 | 0.86 | 0.77 | 0.77 |
| Working Capital Turnover Ratio | 2.85 | 5.57 | 17.52 | 7.18 | 7.74 |
| Cash Conversion Cycle | 122.88 | 122.88 | 69.58 | 68.32 | 70.81 |
| Days of Sales Outstanding | 118.97 | 100.86 | 62.97 | 48.82 | 48.18 |
| Days of Inventory Outstanding | 68.19 | 68.83 | 42.51 | 52.68 | 52.60 |
| Days of Payables Outstanding | 64.27 | 46.81 | 35.89 | 33.18 | 29.98 |
| Operating Cycle | 187.15 | 169.69 | 105.47 | 101.49 | 100.79 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 9.72 | -0.26 | 1.20 | -7.78 | -2.12 |
| Free Cash Flow Per Share | 5.20 | -3.03 | -3.61 | -13.07 | -8.25 |
| Dividend Paid and CapEx Coverage Ratio | 2.15 | -0.10 | 0.25 | -1.47 | -0.35 |
| Capital Expenditure Coverage Ratio | 2.15 | -0.10 | 0.25 | -1.47 | -0.35 |
| Operating Cash Flow Coverage Ratio | 0.07 | -0.00 | 0.01 | -0.06 | -0.02 |
| Operating Cash Flow to Sales Ratio | 0.03 | -0.00 | 0.00 | -0.03 | -0.01 |
| Free Cash Flow Yield | 1.69% | -1.69% | -2.46% | -10.91% | -4.55% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 8.11 | -9.01 | -3.15 | -4.57 | 4.31 |
| Price-to-Sales (P/S) Ratio | 0.95 | 0.69 | 0.43 | 0.39 | 0.58 |
| Price-to-Book (P/B) Ratio | 1.60 | 1.30 | 0.84 | 0.65 | 0.87 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 59.02 | -59.19 | -40.61 | -9.16 | -21.99 |
| Price-to-Operating Cash Flow Ratio | 31.59 | -679.06 | 121.95 | -15.40 | -85.47 |
| Price-to-Earnings Growth (PEG) Ratio | -0.03 | 0.16 | -0.04 | 0.03 | 0.00 |
| Enterprise Value Multiple | 6.94 | -62.31 | -7.68 | -17.70 | 3.73 |
| Enterprise Value | 1.36B | 1.02B | 806.63M | 717.70M | 874.74M |
| EV to EBITDA | 6.94 | -62.31 | -7.68 | -17.70 | 3.73 |
| EV to Sales | 1.22 | 1.06 | 0.71 | 0.70 | 0.84 |
| EV to Free Cash Flow | 75.83 | -90.63 | -67.25 | -16.51 | -31.89 |
| EV to Operating Cash Flow | 40.59 | -1039.76 | 201.96 | -27.74 | -123.97 |
| Tangible Book Value Per Share | 220.48 | 138.77 | 175.27 | 171.37 | 195.92 |
| Shareholders’ Equity Per Share | 191.63 | 138.15 | 174.28 | 184.67 | 208.57 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.03 | 0.21 | 0.11 | 0.08 | 0.21 |
| Revenue Per Share | 322.36 | 259.82 | 340.88 | 306.98 | 313.15 |
| Net Income Per Share | 37.86 | -19.89 | -46.56 | -26.20 | 42.08 |
| Tax Burden | 1.01 | 0.81 | 0.89 | 0.93 | 0.78 |
| Interest Burden | 0.82 | 1.40 | 1.17 | 1.23 | 0.91 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.02 | 0.02 | 0.01 | 0.01 | 0.01 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.26 | 0.01 | -0.03 | 0.30 | -0.05 |
Currency in ILS